Switch to:
Horizon Pharma PLC (NAS:HZNP)
EV/EBITDA
14.16 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Horizon Pharma PLC's enterprise value is $2,742.9 Mil. Horizon Pharma PLC's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Dec. 2015 was $193.7 Mil. Therefore, Horizon Pharma PLC's EV/EBITDA ratio for today is 14.16.

HZNP' s EV/EBITDA Range Over the Past 10 Years
Min: -608   Max: 518
Current: 14.16

-608
518

During the past 8 years, the highest EV/EBITDA Ratio of Horizon Pharma PLC was 518.00. The lowest was -608.00. And the median was -0.50.

HZNP's EV/EBITDA is ranked higher than
60% of the 552 Companies
in the Global Drug Manufacturers - Specialty & Generic industry.

( Industry Median: 16.66 vs. HZNP: 14.16 )

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Horizon Pharma PLC's stock price is $15.37. Horizon Pharma PLC's earnings per share for the trailing twelve months (TTM) ended in Dec. 2015 was $0.21. Therefore, Horizon Pharma PLC's P/E Ratio for today is 73.89.

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Horizon Pharma PLC's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=2742.923/193.715
=14.16

Horizon Pharma PLC's current Enterprise Value is $2,742.9 Mil.
Horizon Pharma PLC's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Dec. 2015 was 23.099 (Mar. 2015 ) + -0.765 (Jun. 2015 ) + 89.014 (Sep. 2015 ) + 82.367 (Dec. 2015 ) = $193.7 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Horizon Pharma PLC's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=15.37/0.208
=73.89

Horizon Pharma PLC's share price for today is $15.37.
Horizon Pharma PLC's Earnings Per Share for the trailing twelve months (TTM) ended in Dec. 2015 was -0.16 (Mar. 2015 ) + 0.2 (Jun. 2015 ) + 0.02 (Sep. 2015 ) + 0.148 (Dec. 2015 ) = $0.21.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Horizon Pharma PLC Annual Data

Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15
ev2ebitda 0.000.000.000.000.00-0.69-1.21-15.9267.6219.34

Horizon Pharma PLC Quarterly Data

Sep13Dec13Mar14Jun14Sep14Dec14Mar15Jun15Sep15Dec15
ev2ebitda -4.04-15.92-104.06511.09-696.4367.6284.25140.4026.4419.34
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK